Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Role of bone marrow imprints in haematological diagnosis: a detailed study of 3781 cases.

Gong X, Lu X, Wu X, Xu R, Tang Q, Xu G, Wang L, Zhang X, Zhao X.

Cytopathology. 2012 Apr;23(2):86-95. doi: 10.1111/j.1365-2303.2010.00825.x. Epub 2010 Dec 3.

PMID:
21129051
2.
3.

The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.

Xubo G, Xingguo L, Xianguo W, Rongzhen X, Xibin X, Lin W, Lei Z, Xiaohong Z, Genbo X, Xiaoying Z.

Eur J Haematol. 2009 Oct;83(4):292-301. doi: 10.1111/j.1600-0609.2009.01283.x. Epub 2009 Jun 2.

PMID:
19500135
4.

[Application of bone marrow biopsy imprint in evaluating cellularity].

Lu XG, Huang LS, Xu XH, Yang JJ, Zhu L, Zhao XY, Xu GB.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 May;35(3):331-5. Chinese.

PMID:
16764040
5.
6.
7.

Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative.

Buño I, Nava P, Alvarez-Doval A, Alvarez-Rodríguez F, Díez-Martín JL, Menárguez J.

J Clin Pathol. 2005 Jun;58(6):629-33.

8.
10.

[Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].

Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ.

Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):3-7. Chinese.

PMID:
19563026
11.
12.

Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.

Kumar S, Rau AR, Naik R, Kini H, Mathai AM, Pai MR, Khadilkar UN.

Indian J Pathol Microbiol. 2009 Jul-Sep;52(3):332-8. doi: 10.4103/0377-4929.54987.

13.

Comparative evaluation of bone marrow aspirate particle smears, imprints and biopsy sections.

Sabharwal BD, Malhotra V, Aruna S, Grewal R.

J Postgrad Med. 1990 Oct;36(4):194-8.

14.

The bone marrow agar section: a morphologic and immunohistochemical evaluation.

Arber DA, Johnson RM, Rainer PA, Helbert B, Chang KL, Rappaport ES.

Mod Pathol. 1993 Sep;6(5):592-8.

PMID:
8248117
15.

Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.

Huh HJ, Min HC, Cho HI, Chae SL, Lee DS.

Cancer Genet Cytogenet. 2008 Oct;186(1):1-5. doi: 10.1016/j.cancergencyto.2008.04.012.

PMID:
18786435
16.

Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.

Ríos A, Cañizo MC, Sanz MA, Vallespí T, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF.

Br J Haematol. 1990 May;75(1):26-33.

PMID:
2375920
17.

Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.

Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM.

Leuk Res. 1996 Jul;20(7):563-74.

PMID:
8795690
18.

Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.

Schwonzen M, Pohl C, Steinmetz T, Wickramanayake PD, Thiele J, Diehl V.

Br J Haematol. 1992 Jul;81(3):362-9.

PMID:
1382545
20.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664

Supplemental Content

Support Center